These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7707422)

  • 1. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4.
    Kolber DL; Knisely TL; Maione TE
    J Natl Cancer Inst; 1995 Feb; 87(4):304-9. PubMed ID: 7707422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity.
    Maione TE; Gray GS; Hunt AJ; Sharpe RJ
    Cancer Res; 1991 Apr; 51(8):2077-83. PubMed ID: 1706960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans.
    Dehmer GJ; Fisher M; Tate DA; Teo S; Bonnem EM
    Circulation; 1995 Apr; 91(8):2188-94. PubMed ID: 7697848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion of recombinant platelet factor-4 suppresses metastases to the lungs from tumors implanted into the livers of rabbits.
    Yoshimitsu K; Wright KC; Wallace S; Charnsangavej C; Mavligit GM
    Cancer; 1995 May; 75(10):2435-41. PubMed ID: 7736386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4.
    Sharpe RJ; Byers HR; Scott CF; Bauer SI; Maione TE
    J Natl Cancer Inst; 1990 May; 82(10):848-53. PubMed ID: 1692094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma.
    Walsh P; Dorner A; Duke RC; Su LJ; Glode LM
    J Natl Cancer Inst; 1995 Jun; 87(11):809-16. PubMed ID: 7791230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor efficacy of reticulol from Streptoverticillium against the lung metastasis model B16F10 melanoma. Lung metastasis inhibition by growth inhibition of melanoma.
    Lim DS; Kwak YS; Kim JH; Ko SH; Yoon WH; Kim CH
    Chemotherapy; 2003 Jun; 49(3):146-53. PubMed ID: 12815208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.
    Rosenberg SA; Mulé JJ; Spiess PJ; Reichert CM; Schwarz SL
    J Exp Med; 1985 May; 161(5):1169-88. PubMed ID: 3886826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a nude mouse tumor model using beta-galactosidase-expressing melanoma cells.
    Dooley TP; Stamp-Cole M; Ouding RJ
    Lab Anim Sci; 1993 Feb; 43(1):48-57. PubMed ID: 7681492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone is increased in the lungs and enhances experimental lung metastasis of melanoma in DJ-1 KO mice.
    Chien CH; Lee MJ; Liou HC; Liou HH; Fu WM
    BMC Cancer; 2016 Nov; 16(1):871. PubMed ID: 27825319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant platelet factor 4 for heparin neutralization.
    Mixon TA; Dehmer GJ
    Semin Thromb Hemost; 2004 Jun; 30(3):369-77. PubMed ID: 15282660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case series of recombinant platelet factor 4 for heparin reversal after cardiopulmonary bypass.
    Demma L; Levy JH
    Anesth Analg; 2012 Dec; 115(6):1273-8. PubMed ID: 22859690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation.
    Bahrambeigi V; Ahmadi N; Salehi R; Javanmard SH
    Immunol Invest; 2015; 44(3):216-36. PubMed ID: 25565576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
    Albini A; D'Agostini F; Giunciuglio D; Paglieri I; Balansky R; De Flora S
    Int J Cancer; 1995 Mar; 61(1):121-9. PubMed ID: 7705924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
    Pearlstein E; Ambrogio C; Karpatkin S
    Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of experimental metastasis and cell adhesion of murine melanoma cells by chondroitin sulfate-derivatized lipid, a neoproteoglycan with anti-cell adhesion activity.
    Karasawa K; Sugiura N; Hori Y; Suzuki S; Onaya J; Sakurai K; Kimata K
    Clin Exp Metastasis; 1997 Mar; 15(2):83-93. PubMed ID: 9062384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinoma.
    Belman N; Bonnem EM; Harvey HA; Lipton A
    Invest New Drugs; 1996; 14(4):387-9. PubMed ID: 9157074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma.
    Bousquet PF; Paulsen LA; Fondy C; Lipski KM; Loucy KJ; Fondy TP
    Cancer Res; 1990 Mar; 50(5):1431-9. PubMed ID: 2302708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency.
    Keyser J; Schultz J; Ladell K; Elzaouk L; Heinzerling L; Pavlovic J; Moelling K
    Exp Dermatol; 2004 Jun; 13(6):380-90. PubMed ID: 15186325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.